Recent Material Events - Generex Biotech (GNBT)

Filing Date	Description
2008-10-10	Material event, click here to read
2008-09-25	On September 9, 2008, Generex Biotechnology Corporation ("the “Company”) received payment of the USD $500,000 non-refundable license fee due following execution of the product licensing and distribution agreement that the Company enter ...
2008-09-10	On February 1, 2006, the Company engaged Danziger (formerly known as Danziger & Hochman, Chartered Accountants) to serve as the Company’s independent auditors for the fiscal year ending July 31, 2006. During the Company’s fiscal yea ...
2008-08-25	On August 25, 2008, Generex Biotechnology Corporation (the “Company”) is issuing a press release to announce that it has entered into a product licensing and distribution agreement with Dong Sung Pharm Co. Ltd. (“Dong-Sung” ...
2008-08-01	On July 29, 2008 and July 31, 2008, Generex Biotechnology Corporation (the “ Company ”) entered into Consent and Waiver Agreements with each of the Investors that purchased the Company’s 8% Senior Secured Convertible Notes (the ...
2008-05-01	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-04-02	On March 31, 2008, Generex Biotechnology Corporation (the “Company” or “Generex”) entered into a Securities Purchase Agreement and related documents with existing institutional investors relating to a private placement of ...
2008-03-14	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ...
2007-12-05	The Board of Directors of Generex Biotechnology Corporation (the “Company”) amended Article IV of the Company's Amended and Restated By-Laws (the "By-Laws"), effective as of December 3, 2007, to allow for the issuance of uncertificate ...
2006-09-14	On September 8, 2006, the Board of Directors of Generex Biotechnology Corporation (the “Company”) accepted the unanimous recommendation of the Company’s Compensation Committee and awarded bonuses to certain of the Company’s... ...